Human Immunodeficiency Virus (HIV) Diagnosis & Treatment – Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast to 2022
The global Human Immunodeficiency Virus (HIV) diagnosis & treatment market is expected to grow at a CAGR of 7.6 % during 2017-2022
Pune, India – May 18, 2018 /MarketersMedia/ —
Global HIV Diagnosis & Treatment Industry
Latest Report on HIV Diagnosis & Treatment Market Global Analysis & 2022 Forecast Research Study
Market insights:
The global Human Immunodeficiency Virus (HIV) diagnosis & treatment market is expected to grow at a CAGR of 7.6 % during 2017-2022. The HIV impact on the immune system of human body and weakens the individual defense system against any infections. It attacks & destroys a type of white blood cell, T-helper cell and replicates. Its produces have several copies of itself inside these white blood cells. Progressively the immune system becomes weak to any kind of infections. This condition and situation is known as acquired deficiency syndrome (AIDS). According to world health organization (WHO), it is a main global public health issue. In 2015, 1.2 million people died with HIV related infections across the globe and approximately 36.8 million people are currently suffering from HIV. As a result, the global HIV diagnosis and treatment market is rapidly growing, and continuously working on trials for the proper diagnosis followed by treatment. The market for HIV diagnosis and treatment market is growing at the pace, and also the increasing occurrence of HIV/AIDS infection globally boosting is the market, also government taking initiatives diagnosis and treatment and increasing in blood donations and blood transfusions and increasing awareness about HIV/AIDS. One of the major reason for the increase in the number of HIV infection across the globe, includes, changing lifestyle, injection drug usage, and lack of awareness and unprotected sex in some region. A prime factor driving the market for HIV diagnosis and treatment market is government and Non-governmental organizations (NGOs) efforts to initiate against HIV/AIDS.
Try Sample Report @ https://www.wiseguyreports.com/sample-request/2786798-global-hiv-diagnosis-treatment-market-research-and-forecast-2017-2022
The HIV diagnosis & treatment market was segmented majorly on the basis of type, product, treatment, and end user. On the basis of type, the market is further segmented into antibody tests, viral identification assays, cd4 testing, viral load testing, and early infant diagnostics. Antibody tests have a largest market share in the diagnosis of AID. On the basis of product, HIV diagnosis & treatment market can be segmented into assays and kits & reagents, instruments and software & service. In product segment, the product assays and kits is anticipated to lead the growth of the global HIV diagnosis & treatment market during the next few years. On the basis of treatment HIV diagnosis & treatment market can be segmented into protease inhibitors (PIS), non-nucleoside reverse transcriptase inhibitors (NNRTIS), nucleoside or nucleotide reverse transcriptase inhibitors (NRTIS), entry or fusion inhibitors, integrase inhibitors and others. In the treatment segment, the protease inhibitors (PIS) are the main treatment for the t global HIV Diagnosis & Treatment Market.
Geographical insights
North America and Europe are the leading the market of the global HIV diagnosis & treatment market having strong healthcare R&D scenario. Regional government is taking initiatives for the ongoing diagnostic efforts for development of new treatment and products. Asia Pacific is anticipated to grow at the high pace due to many issues regarding screening and testing of HIV. Furthermore, partnerships among the western market players and the governments in the region are another major aspect fueling the growth of HIV diagnosis market.
Competitive Insights:
The main players functioning in the global HIV diagnosis & treatment market include Siemens Healthcare, Abbott Laboratories, Roche molecular systems Inc., Bio-Rad laboratories, QIAGEN, Danaher Corporation, Becton, Dickinson and company, Merck KGAA, Biomerieux SA, Medmira Inc., Hologic Inc., Alere Inc., and others. In 2015, the U.S. food and drug administration (FDA) has approved the Siemens ADVIA Centaur HIV Ag/Ab combo (CHIV) assay.
Market segmentation:
1. HIV diagnosis & treatment market research and analysis, by type
2. HIV diagnosis & treatment market research and analysis, by product
3. HIV diagnosis & treatment market research and analysis, by treatment
4. HIV diagnosis & treatment market research and analysis, by user
The Report Covers:
• Comprehensive research methodology of HIV diagnosis & treatment market.
• This report also includes detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the HIV diagnosis & treatment market.
• Insights about market determinants which are stimulating the HIV diagnosis & treatment market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/2786798-global-hiv-diagnosis-treatment-market-research-and-forecast-2017-2022
Some points from table of content:
REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
MARKET DETERMINANT
3.1. MARKET MOTIVATORS
3.1.1. FAVOURABLY REGULATORY LANDSCAPE
3.1.2. POC HIV DIAGNOSTICS DEVELOPMENT
3.1.3. DEVELOPMENT OF SINGLE BLOOD DROP ANALYSER FOR HIV TEST
3.1.4. INCREASING HIV/AIDS PREVALENCE
3.1.5. INCREASING NUMBER OF BLOOD TRANSFUSIONS AND BLOOD DONATIONS
3.1.6. INCREASING GOVERNMENT INITIATIVES
3.2. RESTRAINT
3.2.1. LOW DEGREE OF PENETRATION IN UNDEVELOPED REGIONAL MARKETS
3.2.2. STRINGENT REGULATORY REQUIREMENTS FOR THE APPROVAL AND COMMERCIALIZATION OF NEW DRUGS AND THERAPY
3.3. OPPORTUNITY
3.3.1. RISE IN NUMBER OF HIV INFECTION ACROSS THE GLOBE.
3.3.2. INCREASE IN TECHNOLOGY ADVANCEMENT FOR THE DIAGNOSIS AND TREATMENT FOR THE HIV
Continued…….
For more information or any query mail at sales@wiseguyreports.com
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym
Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
For more information, please visit https://www.wiseguyreports.com/sample-request/2786798-global-hiv-diagnosis-treatment-market-research-and-forecast-2017-2022
Source: MarketersMedia
Release ID: 347188
Copyright © 1999-2013 SproutNews.com
